newsplain.

Health

Mosquitoes Bred to Carry Bacteria Sharply Cut Dengue in Brazil Trial

A four-year experiment in a Brazilian city tested whether mosquitoes carrying a bacterium that does not hurt people could shield schoolchildren from viruses.

Genetic Study Ties 58 Regions of the Genome to Endometriosis

Scientists combined biobank records from several continents to search for the biology behind a painful condition. The work guides future research and does not yield a test.

South Korea Confirms First Homegrown Cholera Case in a Decade

Health authorities in a southeastern city are retracing one patient's meals and movements after a confirmation that took more than ten days to complete.

Missouri Court Clears $7.25 Billion Bayer Settlement Over Roundup Cancer Claims

A St. Louis court has cleared a two-decade payment plan meant to settle current and future weed killer lawsuits, though some claims remain outside the deal.

FDA Rejects Capricor's Duchenne Cell Therapy Over Trial Data Flaws

Federal regulators turned down the company's application for deramiocel and pointed to problems in how a key study was run. Capricor stock fell sharply after hours.

Alzheimer's Blood Marker Also Flags Advanced CTE, Study Finds

Researchers say a protein already used in Alzheimer's research could one day help diagnose a brain disease now confirmed only at autopsy, but the early results come with big caveats.

148 Sickened on Caribbean Princess Cruise, Cause Still Unknown

A Princess Cruises voyage out of Fort Lauderdale has a gastrointestinal outbreak with no identified cause, and the ship is not due back in port until Nov. 23.

FDA Approves Regeneron's Livsayis, a Quarterly Injection for Myasthenia Gravis

The agency cleared a new RNA-based drug for adults with an autoimmune muscle disease, and it comes with a restricted-access safety program tied to vaccination.

FDA Approves Sanofi Pill for Neurological Form of Gaucher Disease

Regulators cleared a once-daily pill for a rare inherited disorder, offering the first approved option aimed at the neurological side of the illness.

OpenAI Rolls Out Computer-Use AI Agents for Health Records and Insurance Portals

OpenAI's new healthcare agents operate patient-chart software and insurer portals, and the company's own tests found nearly all sampled tasks clinically safe.

Hims & Hers Starts Selling Compounded Peptides as Experts Warn of Thin Evidence

The telehealth company is offering longevity treatments that regulators have not approved, riding a federal policy shift that outside scientists say outpaces the research.

FDA Launches Program to Share Drug Approval Files With Foreign Regulators

The agency says the program is meant to cut duplicate reviews abroad, and it starts with a narrow set of HIV-related approvals before a planned expansion.

Virtual Exercise Program Speeds Concussion Recovery in Young People, Trial Finds

A trial of video-guided home exercise found young people improved sooner than with stretching, but the advantage was limited to those who began soon after injury.

FDA Grants Accelerated Approval to GSK's Nelkarmi for ALK-Positive Lung Cancer

The once-daily pill is cleared for adults who have already tried other targeted drugs, and the approval came ahead of the agency's original target date.

FDA Approves Lembaz for Rare Infantile-Onset Niemann-Pick Disease

The agency cleared a spinal-canal injection that it says is the first therapy shown to help patients with this inherited disorder live longer.

USDA Warns of Breakfast Items Made With Recalled Biscuits

A federal alert covers ready-to-eat foods carried by vending machines and workplace break rooms, and officials say more products may be added.

FDA Clears Novartis Drug Cosentyx for Polymyalgia Rheumatica

Novartis wins a new U.S. use for its psoriasis and arthritis drug, giving adults with an inflammatory condition an option besides long-term steroids.

UN Report Warns Hormone-Altering Chemicals Can Affect Babies Before Birth

Two UN agencies say a new global review finds wider health risks from everyday chemicals, yet most substances on the market have never been screened for the hazard.

Breckenridge Recalls One Lot of Propranolol Capsules Over Possible Metal

A drugmaker pulled a single batch of a widely used heart and blood pressure medicine from the U.S. market, saying metal pieces may have slipped into the capsules.

Four Women Settle Straightener Cancer Claims Against L'Oreal Mid-Trial

The first trial over cancer claims tied to hair-relaxer products ended early with a confidential deal, leaving thousands of similar lawsuits pending.

FDA Clears Igalmi as First Home Option for Agitation in Schizophrenia, Bipolar Disorder

An FDA decision lets adults with schizophrenia-related illness or bipolar disorder use Igalmi, a film that dissolves in the mouth, at home during agitation episodes.

Final HIPAA Rule Cuts Record-Release Time to 15 Days

A Nov. 16, 2026, rule also eases electronic copies through personal health apps and sets later compliance deadlines.

Roche Pill Wins U.S. Clearance After Breast Cancer Trial

Giredestrant, paired with everolimus, slowed the cancer in people who carry a frequent resistance mutation.

Syria Opens Second Polio Vaccination Round to Contain Deir ez-Zor Outbreak

Health teams aim to reach more than 49,000 young children in Syria's Deir ez-Zor province after three polio cases were recorded around al-Mayadin.

England's Health Adviser Backs Wider Use of Swallowed Sponge Cancer Test

Draft advice for England's NHS would extend a seven-minute capsule test, which gathers cells without a hospital endoscopy, to more people with chronic acid reflux.

Lilly Reports New Obesity Drug Results at ObesityWeek Conference

Eli Lilly released early figures on Nov. 14 from obesity drug trials, including an experimental combination shot and Zepbound in teenagers, ahead of full results.

U.S. Mine Safety Agency Proposes Changes to Silica Exposure Protections

The Mine Safety and Health Administration on Nov. 10 proposed changing how mines test for silica dust and how violations are cited, drawing sharp reactions.

Canada's Health Care Bill Projected at Record $433 Billion for 2026

A national report puts the per-person cost above $10,000 for the first time, but health policy experts question whether the money is buying patients better care.

FDA Rejects Summit's Lung Cancer Drug Ivonescimab Over Survival Data

The agency said slowing tumor growth was not enough without proof that patients lived longer, a setback for a closely watched type of cancer drug.

Electric Comb Regrows Nearly All Lost Hair in Mouse Study

Researchers in Beijing built a drug-delivering comb for pattern baldness, but the device has yet to be tried on a single human scalp.

FDA Clears Daily Pill Pimjetmi for Rare Joint Tumor TGCT

The once-daily drug becomes the third of its class cleared for a tumor that can stiffen and damage joints, after a trial showed most patients' tumors shrank.

Quitting GLP-1 Drugs Tied to Doubled Heart Risk in Type 2 Diabetes

An Italian study of more than 80,000 patients found a sharp gap between people who stayed on the drugs and those who stopped, but researchers urge caution.

WHO Sets First Global Standards for Adult Type 1 Diabetes Care

The guidance favors lower-cost human insulin and regular blood sugar checks, and it is written to work even in emergencies and poor clinics.

One-Time CRISPR Treatment Holds Down Monkey Triglycerides for Three Years

The Eli Lilly-owned developer behind the work is already testing a human version in patients whose cholesterol stays high on standard drugs.

Children in England Received 419 GLP-1 Prescriptions in 2025-26

Freedom of information figures show the obesity drugs reaching some patients younger than 12, and the totals leave out private and hospital prescriptions.

FDA Approves First Drug Specifically for Primary Membranous Nephropathy

A Roche antibody already used for blood cancers and lupus kidney disease beat an older off-label drug in a two-year trial.

FDA Approves Imfinzi Regimen for Bladder Cancer Patients Who Cannot Take Cisplatin

The decision rests on a late-stage trial in which the drug pairing lowered the risk of death by 42% versus the comparison group.

Resting Brain Scans May Flag Alzheimer's Risk Years Ahead

Stanford researchers built a score from the brains of exceptional older adults and of patients with the disease, then tested it on healthy people.

Study Finds Blood Marker Tied to Advanced CTE

Researchers say the protein fragment could one day help track a brain disease that can now be confirmed only after death.

Addiction Doctors Issue First Guidance on Medetomidine Withdrawal

An animal sedative spreading through the illegal drug supply can trigger withdrawal that standard treatments do not control, a doctors' group warned.

Synchron Pauses Brain Implant Trials Over Cable Problem

A company working to let people control devices with their thoughts has stopped adding patients while it reworks its hardware.

China Approves Eli Lilly Oral Weight-Loss Pill

Regulators cleared the first daily tablet in a popular class of obesity medicines, giving the U.S. drugmaker a lead over a rival still waiting on a similar decision.

FDA Stops Granting New Priority Review Vouchers

A fast-track drug review pilot appears to have stalled, even as the health department says the project has not been shut down.

CDC Ends Direct HIV Prevention Grants to Texas Groups

Community clinics that tested thousands of people each year are looking for new money after a long-running federal award was allowed to lapse.

American Cancer Society Recommends Routine Prostate Cancer Screening

The group now tells most men to get a regular blood test, a shift from a long-standing emphasis on talking the choice over with a doctor first.

CDC Finds Many GLP-1 Users Skip or Cut Their Doses

A new federal survey looks at how Americans actually take the popular diabetes and weight-loss drugs, and why many depart from their prescriptions.

Watchdog Finds Serious Governance Shortcomings at NHS Grampian

The findings prompted an apology from NHS Grampian’s chief executive, while Scotland’s health secretary is considering further steps.

ARPA-H Commits Up to $4.9 Million for Ibogaine Trial Preparation

Two selected teams will develop research data and a domestically made drug product, but the announcement describes groundwork rather than patient trials.

GMC Warns Burnout Could Threaten Maternity Patient Safety

Survey responses also point to sleep loss and reluctance to seek senior advice among doctors training in the specialty.

Three Drugs Beat Prozac on Long-Term Depression Response

Henricus G. Ruhé, a psychiatry researcher at Radboud, said: “Our results cannot predict that a certain drug will be effective in an individual.”

Study Tests Waist Measures Alongside BMI in Obesity Classification

The research compares an expanded approach to diagnosis with a widely used measure, raising questions about how obesity is assessed in clinical care.

Wrist Device Uses Electrical Pulses to Target Tourette Tics

The wearable is one of two digital approaches assessed for tic disorders, while access and the evidence base remain unsettled.

Welsh Libraries Start Lending Free SAD Kits

The borrowing model gives residents a way to try a lamp and related guidance without paying its retail price upfront.

WHO Says Ebola Outbreak Expanding in Parts of DRC

The WHO director-general says insecurity is obstructing the response, while delayed payments risk strikes and community tension.

Casey Says Governments Were “asleep at the wheel” on Care

New research points to uneven provision and different costs for people funding care themselves; final recommendations are due next summer.

Cwm Taf Health Visitor Strike Settlement Reached

The agreement offers a way forward for a service disrupted by a long-running dispute over job grading.

St George’s Urges Flu Vaccination Across Surrey and South London

A local vaccination appeal follows an increase in flu cases, while national surveillance shows different trends across measures of activity.

Coventry Woman Raises Awareness of Neuroendocrine Cancer

The condition can be difficult to recognize because its symptoms may resemble those of other illnesses.

Guernsey Allergy Leads Request EURneffy Listing

The proposal would give local decision-makers a needle-free treatment option to assess for people with severe allergic reactions.

Scotland’s First Blood-Supply Amber Alert Takes Effect

Hospitals have been asked to conserve a particularly important blood group while the transfusion service seeks more donors.